Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000703671 | SCV000832581 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-04-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406641 | SCV002716802 | uncertain significance | Cardiovascular phenotype | 2022-09-25 | criteria provided, single submitter | clinical testing | The p.S589L variant (also known as c.1766C>T), located in coding exon 11 of the FLNC gene, results from a C to T substitution at nucleotide position 1766. The serine at codon 589 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002477623 | SCV002804031 | uncertain significance | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2021-12-28 | criteria provided, single submitter | clinical testing |